Taken together, dyslipidemia in diabetic nephropathy mice was ameliorated by the downregulation of HNF4A and activation of AMPK and SIRT1, which could be related to abnormal lipid metabolism in renal podocytes in diabetic nephropathy. This evidence concerns the gene HNF4A and diabetic kidney disease.